328 related articles for article (PubMed ID: 9109972)
41. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
42. [antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease].
Papo M; Quer JC; Pastor RM; García-Pardo G; Olona M; Prats E; Mirapeix E; Rodríguez R; Richart C
Med Clin (Barc); 1998 Jan; 110(1):11-5. PubMed ID: 9527980
[TBL] [Abstract][Full Text] [Related]
43. Tobacco dependence and awareness of health risks of smoking in patients with inflammatory bowel disease.
Wahed M; Goodhand JR; West O; McDermott A; Hajek P; Rampton DS
Eur J Gastroenterol Hepatol; 2011 Jan; 23(1):90-4. PubMed ID: 21030867
[TBL] [Abstract][Full Text] [Related]
44. Epidemiologic characteristics of 500 patients with inflammatory bowel disease in Iran studied from 2004 through 2007.
Vahedi H; Merat S; Momtahen S; Olfati G; Kazzazi AS; Tabrizian T; Rashtak S; Khaleghnejad R; Khademi H; Malekzadeh F; Nasseri-Moghaddam S; Malekzadeh R
Arch Iran Med; 2009 Sep; 12(5):454-60. PubMed ID: 19722766
[TBL] [Abstract][Full Text] [Related]
45. Preillness non dietary factors and habits in inflammatory bowel disease.
Klein I; Reif S; Farbstein H; Halak A; Gilat T
Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):247-51. PubMed ID: 9759588
[TBL] [Abstract][Full Text] [Related]
46. [Osteoporosis in inflammatory bowel disease - results of a survey among members of the German Crohn's and Ulcerative Colitis Association].
von Tirpitz C; Steder-Neukamm U; Glas K; Sander S; Ring C; Klaus J; Reinshagen M
Z Gastroenterol; 2003 Dec; 41(12):1145-50. PubMed ID: 14661123
[TBL] [Abstract][Full Text] [Related]
47. Risk factors for inflammatory bowel disease in the general population.
García Rodríguez LA; González-Pérez A; Johansson S; Wallander MA
Aliment Pharmacol Ther; 2005 Aug; 22(4):309-15. PubMed ID: 16097997
[TBL] [Abstract][Full Text] [Related]
48. Chronic inflammatory bowel disease and cancer.
Pohl C; Hombach A; Kruis W
Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
[TBL] [Abstract][Full Text] [Related]
49. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study.
Bernstein CN; Wajda A; Blanchard JF
Gastroenterology; 2005 Sep; 129(3):827-36. PubMed ID: 16143122
[TBL] [Abstract][Full Text] [Related]
50. [Epidemiology of inflammatory bowel diseases in Veszprém county of Western Hungary between 1977 and 2001].
Lakatos L; Mester G; Erdélyi Z; Balogh M; Szipócs I; Kamarás G; Lakatos PL
Orv Hetil; 2003 Sep; 144(37):1819-27. PubMed ID: 14596020
[TBL] [Abstract][Full Text] [Related]
51. Smoking cessation and the course of Crohn's disease: an intervention study.
Cosnes J; Beaugerie L; Carbonnel F; Gendre JP
Gastroenterology; 2001 Apr; 120(5):1093-9. PubMed ID: 11266373
[TBL] [Abstract][Full Text] [Related]
52. New insights into IBD epidemiology: Are there any lessons for treatment?
Bernstein CN
Dig Dis; 2010; 28(3):406-10. PubMed ID: 20926864
[TBL] [Abstract][Full Text] [Related]
53. [Idiopathic inflammatory bowel disease--prediction and treatment].
Lukás K
Cas Lek Cesk; 2011; 150(6):315-20. PubMed ID: 21751503
[TBL] [Abstract][Full Text] [Related]
54. Cigarette smoking and ulcerative colitis. A case control study.
Lorusso D; Leo S; Misciagna G; Guerra V
Hepatogastroenterology; 1989 Aug; 36(4):202-4. PubMed ID: 2807139
[TBL] [Abstract][Full Text] [Related]
55. Smoking and inflammatory bowel disease in families.
Smith MB; Lashner BA; Hanauer SB
Am J Gastroenterol; 1988 Apr; 83(4):407-9. PubMed ID: 3348193
[TBL] [Abstract][Full Text] [Related]
56. Epidemiological survey of coeliac disease and inflammatory bowel disease in first-degree relatives of coeliac patients.
Shah A; Mayberry JF; Williams G; Holt P; Loft DE; Rhodes J
Q J Med; 1990 Mar; 74(275):283-8. PubMed ID: 2385735
[TBL] [Abstract][Full Text] [Related]
57. Comparison of the prevalence of fructose and lactose malabsorption across chronic intestinal disorders.
Barrett JS; Irving PM; Shepherd SJ; Muir JG; Gibson PR
Aliment Pharmacol Ther; 2009 Jul; 30(2):165-74. PubMed ID: 19392860
[TBL] [Abstract][Full Text] [Related]
58. Epidemiological evolution of epidemiology of the inflammatory bowel diseases in a hospital of Tunis.
Ouakaa-Kchaou A; Gargouri D; Bibani N; Elloumi H; Kochlef A; Kharrat J
Tunis Med; 2013 Jan; 91(1):70-3. PubMed ID: 23404603
[TBL] [Abstract][Full Text] [Related]
59. Dietary and other risk factors of ulcerative colitis. A case-control study in Japan. Epidemiology Group of the Research Committee of Inflammatory Bowel Disease in Japan.
J Clin Gastroenterol; 1994 Sep; 19(2):166-71. PubMed ID: 7963367
[TBL] [Abstract][Full Text] [Related]
60. A case-control study of ulcerative colitis in relation to dietary and other factors in Japan. The Epidemiology Group of the Research Committee of Inflammatory Bowel Disease in Japan.
J Gastroenterol; 1995 Nov; 30 Suppl 8():9-12. PubMed ID: 8563901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
